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Abstract 
Background 
Multimorbidity is associated with mortality and service use, with specific types of multimorbidity having 
differential effects. Additionally, multimorbidity is often negatively associated with participation in research 
cohorts. Therefore, we set out to identify clusters of multimorbidity patients and how they are differentially 
associated with mortality and service use across age groups in a population representative sample. 
Methods 
Linked primary and secondary care electronic health records contributed by 382 general practices in England 
to the Clinical Practice Research Datalink (CPRD) were used. The study included a representative set of 
multimorbid adults (18 years old or more, N=113,211) with two or more long-term conditions (a total of 38 
conditions were included). A random set of 80% of the multimorbid patients (N=90,571) were stratified by 
age groups and clustered using latent class analysis. Consistency between obtained multimorbidity 
phenotypes, classification quality and associations with demographic characteristics and primary outcomes 
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(GP consultations, hospitalisations,       regular medications and mortality) was validated in the remaining 
20% of multimorbid patients (N=22,640).  
Results 
We identified twenty patient clusters across four age strata. The clusters with the highest mortality comprised 
psychoactive substance and alcohol misuse (aged 18-64), coronary heart disease, depression and pain (aged 
65-84) and coronary heart disease, heart failure and atrial fibrillation (aged 85+). The clusters with the highest 
service use coincided with those with highest mortality for people aged over 65.  For people aged 18-64, the 
cluster with the highest service use comprised depression, anxiety and pain. The majority of 85+ year olds 
multimorbid patients belonged to the cluster with the lowest service use and mortality for that age range. Pain 
featured in thirteen clusters.   
Conclusions 
This work has highlighted patterns of multimorbidity that have implications for health services. These include 
the importance of psychoactive substance and alcohol misuse in people under the age of 65; of co-morbid 
depression and coronary heart disease in people aged 65-84, and of cardiovascular disease in people aged 85+.   
Keywords 
Multimorbidity phenotype, chronic conditions, latent class analysis, pattern recognition, validation, age-
stratification 
Background 
As a result of improved life expectancy and ageing populations, a growing number of individuals are living 
with multimorbidity, i.e. more than one long-term condition [1, 2]. Multimorbidity has been recognised as a 
global challenge for health care management [3] and it is estimated by the Health Foundation that 14 million 
individuals in England have multimorbidity, with over a third of these having more than four long-term 
conditions [4]. Patients with multimorbidity also account for the majority of primary care consultations, 
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prescriptions and hospitalisations in the UK [5].However, current clinical specialities, guidelines, quality 
improvement strategies and quality of care metrics are organised around single diseases [6] and treatments of 
multiple conditions are rarely coordinated, resulting in insufficient or even conflicting care [6, 7]. 
Patients with multimorbidity have a diverse range of diseases, needs and outcomes [4, 5, 8]. Identifying and 
characterising groups of multimorbid patients that share similar patterns of long-term conditions might 
facilitate an improvement in their healthcare. For example, such an approach might aid the development of 
effective strategies for early diagnosis and prevention of multimorbidity, and allow for a better design and 
delivery of targeted interventions [1, 9]. Several systematic reviews have found common multimorbidity 
clusters involving cardiovascular-metabolic conditions, mental health and musculoskeletal disorders [10, 11]. 
However, existing evidence has important limitations. The two largest studies of specific multimorbidity 
groups in the UK have used UK Biobank data where participants are healthier (i.e. less multimorbid), smoke 
and drink less and are from less socioeconomically deprived      areas      than the overall population [12–14]. 
Second, most previous studies have focused on older populations (aged 60+); few have provided age-stratified 
clusters [10, 11, 15], leaving scarce evidence for the younger multimorbid population. Third, multimorbidity 
clusters composed of more than two conditions have not been well profiled mostly due to non-representative 
and smaller samples [1, 10, 11]. Fourth, there is substantial heterogeneity in the number of conditions 
considered (often less than 20) and in the statistical methods. Most studies focused on grouping diseases rather 
than patients, where each disease can only go into one cluster and so it is not straightforward to relate patients 
to outcomes in order to facilitate patient-centred policy-making [16]. Commonly used clustering methods 
were exploratory approaches such as factor analysis and hierarchical clustering [10, 17], where results were 
highly sensitive to the subjective choice of metrics [18]. Finally, the validity and generalisability of cluster 
solutions in new samples is important for decision-making but is often ignored in the current literature [10, 
11]. 
This study aims to identify, validate and study the outcomes of age-stratified clusters of multimorbid adult 
patients in a large representative sample of UK patients. Towards this end we used a comprehensive list of 38 
long-term conditions [5] and a robust model-based probabilistic approach, latent class analysis [18]. 
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Methods 
Data source 
Our analysis used the Clinical Practice Research Datalink (CPRD)-GOLD database where anonymised and 
longitudinal primary care clinical data are contributed by UK general (family) practices (GP) who use the 
Vision health record system [19]. CPRD has been validated to be representative of the UK population for age, 
sex, and ethnicity [19, 20]. Patients’ GP records were linked with hospitalisation data (Hospital Episodes 
Statistics, HES), all-cause mortality data (Office for National Statistics, ONS) and area-based (1,000 – 1,500 
people per area around patients home) socioeconomic deprivation data (Index of Multiple Deprivation, IMD); 
these linked data were available for approximately 75% of English practices in CPRD. The protocol for this 
study (16_057RA2) was approved scientifically and ethically by the CPRD Independent Scientific Advisory 
Committee. 
Study population 
Data on a random selection of individuals were acquired from CPRD (the same individuals studied in Cassell 
et al., [5]). Patients aged 18 years and above with valid registered-status in a practice with data classified by 
CPRD as “up-to-standard” in January 2012 [19] were included in the study. We chose the year 2012 to allow 
complete ascertainment of five-year mortality. Additionally, we required that their practice allowed linkage to 
ONS, IMD and HES, resulting in the inclusion of only English practices. 
Patient and public involvement 
There was no patient or public involvement in this study. 
Statistical software 
Data analysis was performed in R 3.4.4. R package names are given in the following sections where 
appropriate (in brackets and italics), for example memory efficient packages were used to extract data for 
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analysis in R (ff, CALIBERdatamanage). For transparency and reproducibility, all analysis scripts and code 
lists are available from https://github.com/Kiddle-group. 
Definition of patient characteristics, morbidities and outcomes 
Morbidities in this study were defined as binary variables (present or not) based on the classification of LTCs 
in primary care developed by Barnett et al., [8] This taxonomy attempted to include all conditions “likely to 
be chronic (defined as having significant impact over at least the most recent year) and with significant impact 
on patients in terms of need for chronic treatment, reduced function, reduced quality of life, and risk of future 
morbidity and mortality”, and was developed for use in UK primary care electronic health record research and 
has been adapted for use in CPRD [5]. The specific definitions for each LTC is based on the UK Read code 
system and electronic prescription data coded using CPRD’s prodcode, giving a total of 38 LTCs.  
(https://www.phpc.cam.ac.uk/pcu/cprd_cam/codelists/v11/ ). The LTCs used in this study largely match the 
only other large sample size UK multimorbidity cluster study [13]. 
Two sets of outcome variables related to service use and mortality were defined. NHS service utilisation or 
treatment burden was measured by three variables over the 12-month period after January 2012: primary care 
consultations (consultations with any clinician in the primary care team), the number of all-type 
hospitalisation spells (defined by discharge dates) and the count of regular medications      (at least four 
prescriprions      in a year by counting the unique British National Formulary (BNF) codes). All-cause 
mortality at two and five years was extracted from ONS data. 
Patient characteristics that were considered in this study include gender, age groups (stratified into 18-44, 45-
64, 65-84 and 85+ years) in 2012, last recorded pre-2012 body mass index (BMI), last recorded pre-2012 
smoking status (current, never and ex-smokers) and socioeconomic deprivation      measured by quintiles of 
IMD      across the UK (1 for the least socioeconomically deprived quintile of areas and 5 for the most). 
Gender and age were determined in a straightforward manner from the CPRD-GOLD patient table. BMI and 
smoking status were extracted from the CPRD-GOLD clinical and additional tables using CPRD entity type 
13 (BMI), CPRD entity type 4 (smoking status) and a smoking status R     ead code list from Jennifer Quint 
(Imperial College London) which is available at https://github.com/Kiddle-group. 
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Statistical analysis 
This study aims to identify clusters of multimorbid patients using patterns of co-existing long-term conditions. 
We used latent class analysis (LCA) (poLCA) to assign all patients to non-overlapping clusters (i.e. each 
patient is assigned to only one cluster) in a data-driven fashion [21, 22]. Compared to other exploratory 
clustering methods (e.g. factor analysis, hierarchical clustering [11, 23]), LCA is a model-based probabilistic 
clustering approach that is not sensitive to rotation of factors and does not require any subjective choice of 
“distance measures” for multimorbidity patterns [18, 24]. This greatly enhances the reproducibility and 
stability of the latent class solutions. Clustering patients rather than diseases allows diseases to belong to 
multiple clusters and more naturally allows the characteristics and outcomes of clusters to be studied. As a 
result, each derived patient cluster has a unique and probabilistic multimorbidity phenotype profile where 
members do not necessarily need to have all conditions.  
Guided by simulation studies [25], the optimal number of latent classes was decided using a combination of 
statistics (Bayesian Information Criteria (BIC), sample-size-adjusted BIC, log-likelihood ratio test, entropy for 
classification quality) and clinical judgment. Within our datasets conditions are present (i.e. recorded) or not 
by definition, and so missing data methods were not needed for cluster analysis. More details on a technical 
review of commonly used clustering methods, the LCA methodology and application of selection statistics are 
provided in      Additional file 2:     section 3. 
To account for the different nature of multimorbidity clusters at different ages, four age strata (18-44, 45-64, 
65-84, 85+ years) were chosen. We derived the cluster solution and performed post-hoc statistical tests in a 
stratified (by age strata) random sample of the multimorbid population that contained 80% of the patients (i.e. 
training set). Separate LCAs were performed for each stratum, and each patient allocated to a single 
multimorbidity cluster. For ease of interpretation, clusters were labelled by their three most distinctive 
conditions whose difference in prevalence between cluster and age strata were the highest (see      Additional 
file 2: table 1 for full details of conditions). To quantify the association between outcomes, multimorbidity 
clusters and patient demographics, generalised linear models were fitted (see      Additional file 2: section 5). 
In the models for service use and health outcomes, the multimorbidity cluster with the lowest impact on the 
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outcomes were taken as reference. For these models, individuals with missing data for last pre-2012 recording 
of smoking status or BMI represented a small percentage (<5%) of the population, and so were excluded from 
the generalised linear models. Additional sensitivity analyses also using complete-case analysis were 
performed for the entire sample where the non-multimorbid patient group (which had higher missingness of 
smoking and BMI) was taken as reference (see Additional file 2: tables 16-19). 
Assessment of the stability of morbidity clusters 
To assess the stability of age-stratified multimorbidity clusters, LCAs were repeated in the remaining 20% of 
the population (i.e. test set), fixing the number of clusters to match that learned from the training set [26].We 
employed three methods to indirectly validate our cluster solutions (a direct approach was not possible as 
clusters were unobserved). First, to check the consistency between disease profiles for 38 LTCs in the training 
and test sets, each cluster in the test set was matched (using two criteria for robustness) with a corresponding 
cluster in the training set. Matched cluster pairs were selected such that Jensen–Shannon distance [27] (JSD, a 
measure of the divergence between disease profiles) is the smallest and the bivariate Pearson’s correlation 
coefficient [28] (the degree to which two disease profiles co-vary) is the highest (     Additional file 2: tables 
4a, 4b). Second, entropy measures [25] (for classification quality) computed in the training and test sets were 
expected to be similar. Finally, stability was further assessed by observing in the training and test sets similar 
associations (in terms of size, direction and statistical significance) between clusters, patient demographics 
and outcome variables. For more details, see      Additional file 2: section 4. 
Results 
Characteristics of the study population 
A total of 391,669 patients were included in the study, of which 49% and 22% had none or only one long-term 
condition respectively (see Table 1 for patient demographics). Females, older individuals and those from areas 
of greater socioeconomic deprivation had a higher prevalence of multimorbidity. 
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Among the multimorbid patients (i.e. those with more than one long-term condition, N=113,211, 29%), all 
unique combinations of conditions were less than 1% prevalent in the total population with the most prevalent 
20 containing only pairs of conditions (     Additional file 2: table 2). This together with the large number of 
unique combinations of conditions (Additional file 2:     table 3) indicated that multimorbidity patterns were 
highly heterogeneous. Stratified by age strata, Table 2 shows that multimorbidity in the younger population 
(18-44) was more common in areas with greater socioeconomic deprivation while for older groups, the pattern 
is reversed. 
Multimorbidity clusters and outcomes 
For ease of reference we refer to each cluster by its lead or key conditions (i.e. one or three conditions 
respectively, whose cluster-specific prevalence is highest, and higher than their overall prevalence in their 
respective age group). 
These clusters differ across age strata, both in terms of number of clusters per strata and main components 
within each cluster (Table 3 and Additional file 2: figures 1-4). The association between multimorbidity 
clusters and outcomes (service use and mortality) remained significant (p<0·01 in almost all clusters) after 
stratifying by age strata, controlling for socioeconomic deprivation     , BMI, and smoking behaviour 
(     Additional file 2: tables 8-11). Results for the distribution of outcomes (e.g. median, interquartile range 
(IQR)), covariate-adjusted incidence rate ratios (aIRRs) for service utilisation and odds ratios (OR) for 
mortality derived from generalised linear models are available in      Additional file 2: tables 8-15 (adjusted 
covariates were gender, socioeconomic deprivation     , smoking status, BMI, and age)     . 
Age strata: 18-44 year olds 
Five clusters were uncovered in the 18-44 age strata (     Additional file 2: figures 1 & 5), whose lead 
conditions were depression (the most common cluster, 32% of patients in strata), pain (23%), asthma (20%), 
irritable bowel syndrome (18%), and psychoactive substance misuse (7%).      Those in the cluster whose 
three key conditions were depression (within-     cluster prevalence 100%), anxiety (41%) and pain (31%) 
were found to have the highest use of primary care consultations (median 12 [IQR 5-20] in a year). This 
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cluster had an aIRR of primary care consultations of 1.35 (95% confidence interval (CI) 1.28 – 1.43) in 
comparison to the cluster with the lowest service use and mortality (whose lead condition was irritable bowel 
syndrome).  
     Those in the cluster whose three key conditions were pain (36%), hearing loss (30%) and hypertension 
(23%) were found to have the highest hospital admission rates (an average of 0.6 visits in a year) and the 
highest count      of regular medicines      (median 1 [IQR 0-4] unique drug classes in a year). This 
corresponded to an aIRR for hospitalisations of 1.04 [     95% CI 0.90 – 1.20     ] and an aIRR for regular 
medicines      of 1.87 [     95% CI 1.74 – 2.02     ]     relative to the cluster with the lowest service use and 
mortality. 
Highest mortality in this age range was found in the least prevalent (7%) multimorbidity cluster whose three 
key conditions were psychoactive substance misuse (75%), alcohol problems (42%) and depression (24%) 
(3.9% mortality in five years). This level of mortality was 18 times higher than that of individuals in the same 
age range without multimorbidity (0.2%). This cluster was predominantly male (72%),      came from 
socioeconomically deprived areas (63%      from      the most deprived 40% of UK areas) and with high 
smoking rates (76% current smokers). 
Age strata: 45-64 year olds 
In the 45-64 age strata, LCA revealed five clusters (     Additional file 2: figures 2 & 6), whose lead 
conditions were hypertension (the most common cluster, 37% of patients in strata), irritable bowel syndrome 
(24%), depression (22%), asthma (12%) and alcohol problems (4%). Those in the cluster whose three key 
conditions were depression (93%), pain (53%) and anxiety (31%) had the highest number of primary care 
consultations (median 14 [IQR 7-23] in a year, aIRR=1.52 [95% CI 1.47 – 1.58]), hospital admission rates (an 
average of 0.6 visits in a year, aIRR=1.31 [95%  CI 1.31 – 1.44]) and regular medications      (median 4 [IQR 
2-7], aIRR=2.37 [95% CI 2.29 – 2.46]). As in the younger age strata, the least prevalent multimorbidity 
cluster (4%) had the highest death rate (13% in five years, OR=1.08 [95% CI 1.07 – 1.10]     ), its key 
conditions were alcohol problems (62%), psychoactive substance misuse (42%) and pain (28%). Again, this 
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cluster was characterised by being typically male smokers from areas of high socio-economic deprivation. 
Pain as a co-morbidity was represented in all the clusters in this age group.  
Age strata: 65-84 year olds 
Six clusters were found in the 65-84 age strata (     Additional file 2: figures 3 & 7), whose lead conditions 
were hypertension (the most common cluster, 41% of patients in strata), hearing loss (22%), depression 
(14%), coronary heart disease (11%), chronic obstructive pulmonary disease (8%) and pain (5%). The least 
prevalent multimorbidity cluster (5%), whose key conditions were pain (81%), coronary heart disease (53%) 
and depression (45%) had the highest use of primary care consultations (median 23 [IQR 14-35] in a year, 
aIRR=1.92 [95% CI 1.82 – 2.02]), hospital admissions      (an average of 1.6 visits in a year, aIRR=2.15 [95% 
CI 1.94 – 2.40]), regular medicines      (median 11 [IQR 8-14], aIRR =2.88 [95% CI 2.88 – 3.00) and death 
rates (39% mortality in five years).  
Age strata: above 85 year olds 
The 85+ age stratum was composed of four clusters (     Additional file 2: figures 4 & 8), whose lead 
conditions were hypertension (the most common, 58% of patients in strata), pain (23%), heart failure (11%) 
and asthma (8%). The majority of patients (58%) fitted within a cluster whose key conditions were 
hypertension (72%), hearing loss (39%) and diabetes (18%). The cluster with the majority of patients had the 
lowest mortality (50% five-year mortality), as well as the least number of conditions (median 3 [IQR 2-4] 
morbidities), and the least health care utilisation (roughly half the GP contacts, hospitalisations and regular 
medicines       of the cluster whose lead condition was “coronary heart disease”). The cluster with the 
highest mortality, GP contact, hospitalisations and repeat prescriptions comprised a trio of cardiac conditions: 
coronary heart disease, atrial fibrillation and heart failure.  
Validation of cluster morbidity profiles 
As well as validating the clusters by their association with patient characteristics and outcomes, the similarity 
of multimorbidity clusters were compared between the training set (80% of patients, N=90,571) and the test 
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set (the other 20% of patients, N=22,640). Results are summarised below, and given in full in      Additional 
file 2: section 4. Measures of cluster quality (i.e. entropy) were found to be consistent between the training 
and test sets. 
As the training set contained more disease patterns, the derived clusters were more comprehensive. The test 
set (with fewer patients) contained fewer disease patterns and therefore we expected the derived clusters to be 
a subset of those in the training set. Indeed, validation of cluster profiles showed that every cluster in the test 
set found a match in the training set. Some clusters were particularly robust (had the smallest JSD and the 
highest Pearson’s correlation coefficient), for instance, those in the largest age strata (65-84 age strata, N = 
49,494), and clusters whose lead condition was depression, psychoactive drug misuse or alcohol problems. A 
cluster with a less clear match had the lead condition asthma in the 18-44 age strata. 
Discussion 
Summary of results and comparison with other studies 
This study identified and validated clusters of multimorbid patients using a novel patient-centred approach. In 
summary, we identified twenty patient clusters across four age strata. In the younger age-strata (18-44; 45-64), 
the clusters with the highest mortality (18 times higher than the non-multimorbid group in 18-44 year olds) 
comprised psychoactive substance abuse in combination with alcohol problems. The clusters with the most 
contact with general practice in people aged under 65 comprised depression, anxiety and pain. In 65-84 year 
olds, the cluster with the highest mortality and highest health service use (GP contact; hospitalisations; repeat 
prescriptions) comprised pain, coronary heart disease and depression, and in people aged 85 or over, it 
comprised heart failure, coronary heart disease and atrial fibrillation. The most common cluster in 18-44 year 
olds was centred around depression, but in all other age groups, they were centred around hypertension. In the 
oldest age group, this hypertension-centred cluster was associated with the best survival and lowest health 
service use among multimorbid patients. Pain featured in thirteen of the clusters. 
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In this study, unlike most previous analyses of multimorbidity, we have defined novel clusters in terms of 
patients rather than diseases [10, 11].These     clusters have practical implications for service delivery, by 
supporting a move away from healthcare for individual      diseases      towards the care of individuals with 
clusters of conditions     , and thus helping to reduce treatment burden      [29]. The high mortality of the 
cluster of psychoactive substance and alcohol misuse warrants attention. T     he descriptive epidemiology of 
this cluster (male, smoker, under age 65,      relatively low service use, from areas of greater socioeconomic 
deprivation) supports the need for better integration of substance misuse services within primary care, and 
need to provide improved access to holistic management including for physical health      [30]. Conversely, 
we found that the commonest cluster in people aged 85 and over (58% of patients with multi-morbidity in this 
age group) was associated with the least health service use and the lowest mortality. This gives a more 
nuanced perspective on the association of multimorbidity with age that has been widely reported [8], in that it 
suggests that in the oldest age group, multimorbidity per se may be less important, although numerically most 
common. We hypothesise that this is due to a survivor effect, i.e. individuals with more fatal multimorbidity 
often do not reach this age. Our age-stratified approach also enables different patterns of co-morbidity to be 
identified. Thus, in younger age groups, clusters focused around mental health are associated with most GP 
contact, in people aged 65-84, a cluster of mental health and coronary heart disease is associated with most 
GP contact, and other indicators of health service use, whereas in people aged over 85, the cluster representing 
most health service contact is dominated by cardiovascular conditions.  
In terms of relative importance of single conditions within multimorbid clusters, the predominance of mental 
health conditions and hypertension has been identified in previous work [10, 11, 13, 31]. Mental health 
conditions are recognised as having a major impact on health service use over and above physical problems 
[32] and our findings emphasise the importance of ensuring psychological needs are given equal priority to 
physical ones in those clusters of patients where mental health problems are prevalent [33].  A novel finding 
in our work is the inclusion of pain in many of the clusters we identified. This aligns with studies that confirm 
chronic pain is widespread, and emphasises the need to provide integrated pain management services to 
address the potential adverse impact on health service use and both physical and social functioning [34, 35].        
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Strengths and limitations 
The robust identification of such clusters would not have been possible without the novel use of representative 
data reflecting      real-world patterns      of multimorbidity     ,      age-stratification, patient-level clustering 
(not requiring all patients to have identical lists of conditions) and validation with held-out data. This is the 
largest scale application of age-stratified latent class analysis to multimorbidity, both in patient numbers 
(above 100,000) and the number of conditions (38) [11]. By including younger patients and stratifying by age 
we see how multimorbidity clusters differ over the lifecourse. Combining this with the release of reproducible 
analysis scripts is an approach which we recommend for future multimorbidity clustering efforts. Our 
systematic approach including all 38 conditions from Barnett et al., [8], age-stratification, clustering and 
outcomes, was necessary to handle the complexity of multimorbidity in healthcare. 
This study suffers from typical limitations of electronic health record research in that they rely on routine 
coding within the healthcare system including residual confounding and variable CPRD data quality. 
Wherever practically feasible we have taken steps to address these, e.g. the careful design of codelists, relying 
on variables with low missingness and adjusting for key variables. Some relevant information, such as disease 
severity, was not available for the majority of diseases and so were not modelled. This may affect the 
association of disease with characteristics and outcomes. Given the observational nature of this data some 
residual confounding such as this is inevitable, and so we caution that the relationship between clusters, 
patient demographics and outcomes should not be interpreted causally. 
While the clustering approach used (LCA) is a robust probabilistic approach, results may differ subtly if other 
approaches are used. Validation of latent clusters also requires further research where a larger sample size for 
the test set, perhaps from another database or country, can strengthen the validation     . We notice that in 
every age strata there was a cluster whose lead condition (pain, irritable bowel syndrome, hearing loss and 
asthma respectively)  had a within-     cluster prevalence of less than 50%, suggesting that they are less 
distinctive than the other clusters. It is also interesting that they are often the clusters with lowest mortality. 
While these were validated in the test set, it may be that bigger datasets are required to split these into more 
distinct and interpretable clusters. Despite this, given the large and representative sample, the consistency of 
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results both internally, across age strata and with existing literature, we are confident in our main results. 
Finally, multimorbidity evolves over time, but we only use longitudinal data to extract conditions in 2012 and 
service use and mortality outcomes.  
Conclusion 
These multimorbidity clusters highlight major targets for public health and healthcare, giving a more nuanced 
understanding of multimorbidity than the work of Barnett et al., [8] which rely more on simple disease counts. 
The 18-fold higher mortality of younger multimorbid patients with psychoactive substance misuse is a clear 
case of an unmet need. Improving outcomes for this neglected patient group is likely to be feasible given that 
their risk factors (drug use, smoking, deprivation) are potentially amenable to intervention. Conversely, the 
fact that the majority of older multimorbid patients have relatively low service use and mortality has 
implications for the design of health services. More generally, the fact that chronic pain is a key feature of 
many multimorbidity clusters suggest that it is important to manage pain within the context of multimorbidity 
rather than in its own right. Similarly, our findings add to the evidence showing the importance of mental 
health in multimorbid patients, justifying the push for parity of physical and mental health within the 
healthcare system. 
While patients with multimorbidity account for an ever increasing proportion of healthcare need and provision 
[1, 4, 5, 7, 8],  no existing interventions have shown convincing evidence of benefit in improving important 
outcomes [9, 36]. Our findings fit with the suggestion from Salisbury et al., [9] that one reason for the failure 
of previous interventions is that multimorbidity is heterogeneous, with very different diseases, needs and 
outcomes in different groups of patients. Our findings support the proposal that interventions to improve 
outcomes in multimorbidity may be more appropriately targeted on distinct types, and we have systematically 
highlighted groups of patients where tailored approaches could be attempted.  
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